JPRN-UMIN000015841已完成未知
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung Cancer - Phase II Study of nab-paclitaxel in Pretreated Patients with NSCLC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Interstitial pneumonia/lung fibrosis on chest CT. 2) Previous drug allergy 3) History of poorly controlled pleural effusion, pericardial effusion and ascites. 4) Active infection. 5) Current Diarrhea. 6) Ileus or intestinal tract paralysis. 7) Symptomatic brain metastasis. 8) Active concomitant malignancy. 9) History of sever heart disease. 10) History of sever psychological disease. 11) Those judged to be not suitable by the attending physician.
研究者
相似试验
已完成
不适用
Phase II study of nab-paclitaxel in patients with previously treated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012114Osaka City General Hospital30
已完成
2 期
Phase 2 study of Nab-Paclitaxel for patients with previously treated EGFR wild-type non-small-cell lung cancer.on-small-cell lung cancerJPRN-UMIN000018233Shimane university hospital45
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30